| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $12,841,829 ) (Continued on the next page) |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA271145 | Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization | 000 | 3 | NIH | 2/27/2024 | $620,941 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 001 | 4 | NIH | 2/23/2024 | $644,851 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL155078 | Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies | 000 | 4 | NIH | 12/14/2023 | $595,537 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01DK116790 | Improving Kidney Function Assessment in Health and Disease | 000 | 4 | NIH | 11/7/2023 | $642,879 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K08HL146959 | Prevention of Anthracycline Chemotherapy Cardiotoxicity | 001 | 5 | NIH | 4/9/2024 | $160,877 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23DK128657 | Relation between acute changes in kidney function with clinical outcomes among patients with heart failure | 000 | 2 | NIH | 1/18/2024 | $190,883 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers Among Public Housing Residents | 001 | 5 | NIH | 4/22/2024 | $671,650 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL095590 | The Role of Vascular MR-Regulated Genes in Vascular Function and Disease | 000 | 13 | NIH | 3/22/2024 | $706,071 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HS029319 | Improving Equitable Access to Penicillin Allergy De-Labeling | 000 | 2 | AHRQ | 2/14/2024 | $499,933 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL166810 | Monitoring Autophagy in the Heart and in Tumors Treated with Potentially Cardiotoxic Chemotherapy | 000 | 1 | NIH | 1/4/2024 | $762,735 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R13HD115368 | 2024 HOPE Summit | 000 | 1 | NIH | 3/8/2024 | $10,000 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY035702 | Galectin-3 and corneal nerve regeneration | 000 | 1 | NIH | 12/6/2023 | $490,237 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA279808 | Screening for AL Amyloidosis in Smoldering Multiple Myeloma | 000 | 1 | NIH | 2/27/2024 | $861,956 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01NS134859 | Covert Cerebrovascular Disease Detected by Artificial Intelligence (C2D2AI): Pragmatic Neuroimaging Biomarkers for Future Stroke and Dementia Risk | 000 | 1 | NIH | 2/14/2024 | $790,627 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R03AI176091 | Evaluation of tafenoquine for prophylaxis of babesiosis caused by Babesia microti | 000 | 2 | NIH | 1/24/2024 | $80,100 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23DA056847 | Sex-specific Impact of Prenatal Opioids on Brain Reward Signaling and Neonatal Feeding Regulation | 000 | 2 | NIH | 2/23/2024 | $191,160 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL167233 | Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults | 000 | 2 | NIH | 11/21/2023 | $624,710 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL162919 | Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure | 000 | 3 | NIH | 4/11/2024 | $759,586 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01DK128364 | Metabolic Reprogramming by Protease-activated Receptor 2 | 000 | 3 | NIH | 11/30/2023 | $532,143 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA262265 | Modeling Multi-Source Data in Hodgkin Lymphoma | 001 | 3 | NIH | 4/16/2024 | $33,365 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA262265 | Modeling Multi-Source Data in Hodgkin Lymphoma | 000 | 3 | NIH | 3/1/2024 | $600,535 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01CA271145 | Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization | 001 | 3 | NIH | 4/17/2024 | $34,497 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 002 | 4 | NIH | 3/11/2024 | $0 |
| 2024 | 2024 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K23AR078177 | Targeted Peer Coaching to Reduce Fatigue in Lupus: A Patient-Centered Behavioral Intervention | 000 | 3 | NIH | 12/21/2023 | $783 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY032502 | Innate Immunomodulation of Retinal Vascular Development | 001 | 3 | NIH | 2/22/2024 | $175,801 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01AG072911 | Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia | 002 | 3 | NIH | 4/8/2024 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01AG072911 | Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia | 001 | 3 | NIH | 11/7/2023 | $661,257 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K08HL146959 | Prevention of Anthracycline Chemotherapy Cardiotoxicity | 000 | 4 | NIH | 10/31/2023 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01NR018400 | I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for NativeHawaiian Elders | 001 | 4 | NIH | 3/27/2024 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01NR018400 | I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for NativeHawaiian Elders | 000 | 4 | NIH | 12/12/2023 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01AR081791 | Environmental Factors Associated with the Development of Osteoarthritis | 000 | 1 | NIH | 3/12/2024 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01AG066892 | Improving Medical Decision Making for Older Patients with End Stage Renal Disease | 003 | 4 | NIH | 4/18/2024 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01AG066892 | Improving Medical Decision Making for Older Patients with End Stage Renal Disease | 002 | 4 | NIH | 11/9/2023 | $2,466,774 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R13HD111227 | 2023 HOPE Summit | 000 | 1 | NIH | 4/4/2024 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY035220 | Mitochondria and Mustard Damage at the Ocular Surface | 000 | 1 | NIH | 11/15/2023 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY034942 | The role of plasmacytoid dendritic cells in corneal immunity | 000 | 1 | NIH | 12/14/2023 | $0 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R33HL154137 | Functional assay development for tafazzin enzyme replacement candidate selection | 000 | 3 | NIH | 12/29/2023 | $233,607 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | K99HL161321 | Mechanisms of post-preeclampsia hypertension | 000 | 2 | NIH | 4/10/2024 | -$12,464 |
| 2024 | 2023 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01AR076411 | Interpretation and Utility of Novel Composite Structural Endpoints of Cumulative Damage and Disease Activity in Knee Osteoarthritis | 000 | 3 | NIH | 2/29/2024 | -$548,123 |
| 2024 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R61HL154137 | Functional assay development for tafazzin enzyme replacement candidate selection | 000 | 2 | NIH | 12/29/2023 | -$233,607 |
| 2024 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | F32HD103310 | The impact of lifestyle interventions prior to pregnancy on maternal and neonatal adipocyte metabolism | 000 | 3 | NIH | 12/28/2023 | -$11,436 |
| 2024 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HD088061 | Lifestyle Intervention in Preparation for Pregnancy (LIPP) | 000 | 6 | NIH | 4/8/2024 | $0 |
| 2024 | 2022 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01HL119290 | Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and Hypertension | 000 | 8 | NIH | 5/1/2024 | $0 |
| 2024 | 2021 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R21AG070502 | Screening to Improve Survival in AL Amyloidosis | 000 | 2 | NIH | 1/16/2024 | $0 |
| 2024 | 2021 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | U01FD007471 | DDT-BMQ-00086 End-Stage Knee Osteoarthritis as a Prognostic Biomarker for Knee Osteoarthritis Trials | 000 | 1 | FDA | 4/29/2024 | -$6 |
| 2024 | 2020 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | OT2TR003448 | xARA: ARA through Explainable AI | 000 | 1 | NIH | 1/24/2024 | $0 |
| 2024 | 2020 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01EY027315 | Discovery Approach to Ocular Hypertension | 000 | 4 | NIH | 2/15/2024 | -$16 |
| 2024 | 2020 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | R01NS102233 | Enabling Comparative Effectiveness Research in Silent Brain Infarction Through Natural Language Processing and Big Data | 000 | 4 | NIH | 12/12/2023 | $0 |
| 2024 | 2020 | TUFTS MEDICAL CENTER PARENT, INC. | 800 WASHINGTON ST | BOSTON | MA | 02111-1552 | SUFFOLK | USA | U01DK098245 | Vitamin D and Type 2 Diabetes (D2d) | 001 | 8 | NIH | 10/1/2023 | -$18,106 |
|